** Shares of Marlboro maker Altria MO.N up 1.5% at $59.11 in early trade
** Co beats estimates for Q1 sales and profit, helped by rising demand for its smoking alternatives, such as on! nicotine pouches and NJOY vapes
** However, flags an $873 million impairment at its e-cigarette business, where shipments dropped 70% amid a patent dispute
** Co also reiterates its annual adjusted EPS forecast of a 2% to 5% increase, compared with rebased figures for 2024
** Up to last close, stock has risen ~11% YTD
(Reporting by Neil J Kanatt in Bengaluru)
((Neil.JKanatt@thomsonreuters.com;))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。